94 related articles for article (PubMed ID: 9016339)
21. Mechanisms of antiaddictive actions of ibogaine.
Glick SD; Maisonneuve IS
Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
[TBL] [Abstract][Full Text] [Related]
22. In vivo ibogaine blockade and in vitro PKC action of cocaine.
Onaivi ES; Ali SF; Chakrabarti A
Ann N Y Acad Sci; 1998 May; 844():227-44. PubMed ID: 9668681
[TBL] [Abstract][Full Text] [Related]
23. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
Arias HR; Jin X; Feuerbach D; Drenan RM
Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
[TBL] [Abstract][Full Text] [Related]
24. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
[TBL] [Abstract][Full Text] [Related]
25. The development and expression of locomotor sensitization to nicotine in the presence of ibogaine.
Zubaran C; Shoaib M; Stolerman IP
Behav Pharmacol; 2000 Aug; 11(5):431-6. PubMed ID: 11103895
[TBL] [Abstract][Full Text] [Related]
26. Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.
Efange SM; Mash DC; Khare AB; Ouyang Q
J Med Chem; 1998 Nov; 41(23):4486-91. PubMed ID: 9804688
[TBL] [Abstract][Full Text] [Related]
27. Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.
Zubaran C; Shoaib M; Stolerman IP; Pablo J; Mash DC
Neuropsychopharmacology; 1999 Jul; 21(1):119-26. PubMed ID: 10379526
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Antiaddictive Actions of Ibogaine
Glick SD; Maisonneuve IM
Ann N Y Acad Sci; 1998 May; 844(1):214-226. PubMed ID: 29090809
[TBL] [Abstract][Full Text] [Related]
29. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
30. Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax.
Daly JW; Nishizawa Y; Padgett WL; Tokuyama T; McCloskey PJ; Waykole L; Schultz AG; Aronstam RS
Neurochem Res; 1991 Nov; 16(11):1207-12. PubMed ID: 1815136
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells.
Oka K; Andoh T; Watanabe I; Kamiya Y; Ito H
Pflugers Arch; 1998 Nov; 436(6):887-93. PubMed ID: 9799403
[TBL] [Abstract][Full Text] [Related]
32. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
Itzhak Y; Ali SF
Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
[TBL] [Abstract][Full Text] [Related]
33. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
Mellon RD; Bayer BM
J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
[TBL] [Abstract][Full Text] [Related]
34. Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.
Glick SD; Sell EM; Maisonneuve IM
Eur J Pharmacol; 2008 Dec; 599(1-3):91-5. PubMed ID: 18930043
[TBL] [Abstract][Full Text] [Related]
35. Drug discrimination studies with ibogaine.
Helsley S; Rabin RA; Winter JC
Alkaloids Chem Biol; 2001; 56():63-77. PubMed ID: 11705117
[TBL] [Abstract][Full Text] [Related]
36. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
37. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
Xiao Y; Smith RD; Caruso FS; Kellar KJ
J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
[TBL] [Abstract][Full Text] [Related]
38. How toxic is ibogaine?
Litjens RP; Brunt TM
Clin Toxicol (Phila); 2016; 54(4):297-302. PubMed ID: 26807959
[TBL] [Abstract][Full Text] [Related]
39. Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine.
Baumann MH; Pablo J; Ali SF; Rothman RB; Mash DC
Alkaloids Chem Biol; 2001; 56():79-113. PubMed ID: 11705118
[No Abstract] [Full Text] [Related]
40. Noribogaine is a G-protein biased κ-opioid receptor agonist.
Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
